Table 5. Final multivariate logistic regression models predicting occurrence of Lyme disease clinical manifestations in patients, Canada, 2009–2015 (n=1,657).
Explanatory variables | Estimate | Odds ratio | CI at 95% | Wald test | P value |
---|---|---|---|---|---|
Early Lyme disease (erythema migrans) | |||||
10–19 years vs 0–9 years | −0.490 | 0.613 | 0.378–0.994 | 3.932 | 0.047 |
30–39 years vs 0–9 years | −0.513 | 0.599 | 0.378–0.950 | 4.753 | 0.029 |
Early disseminated (neurologic and cardiac symptoms; multiple erythema migrans) | |||||
Male vs female | −0.272 | 0.762 | 0.585–0.992 | 4.083 | 0.043 |
20–29 years vs 0–9 years | 0.678 | 1.969 | 1.071–3.623 | 4.751 | 0.029 |
Year 2010 vs 2015 | −0.555 | 0.574 | 0.392–0.841 | 8.137 | 0.004 |
Late disseminated (arthritis) | |||||
Male vs female | 0.246 | 1.279 | 1.031–1.586 | 5.012 | 0.025 |
75+ years vs 0–14 years | −0.691 | 0.501 | 0.283–0.888 | 5.604 | 0.018 |
Year 2011 vs 2015 | 0.565 | 1.759 | 1.221–2.533 | 9.200 | 0.002 |
Year 2010 vs 2015 | 0.774 | 2.168 | 1.630–2.883 | 28.777 | 0.000 |
Year 2009 vs 2015 | 0.472 | 1.603 | 1.168–2.199 | 8.554 | 0.003 |
Abbreviations: CI, confidence interval